K-V Pharmaceutical Loses FDA Lawsuit Over Makena Drug

K-V Pharmaceutical Co.’s lawsuit alleging that the U.S. Food and Drug Administration’s actions led to “unlawful competition” involving its Makena drug was dismissed by a federal judge.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.